Clinical implications of cytosine deletion of exon 5 of P53 gene in non small cell lung cancer patients

被引:6
|
作者
Mir, Rashid [1 ]
Masroor, Mirza [2 ]
Javid, Jamsheed [1 ]
Ahamad, Imtiyaz [2 ]
Farooq, Shazia [2 ]
Yadav, Prasant [2 ]
Zuberi, Mariyam [2 ]
Lone, Maqbool [3 ]
Ray, P. C. [2 ]
Saxena, Alpana [2 ]
机构
[1] Univ Tabuk, Prince Fahd Bin Sultan Res Chair Canc Mol Genet, Dept Med Lab Technol, Fac Appl Med Sci, Tabuk, Saudi Arabia
[2] Maulana Azad Med Coll & Associated Hosp, Dept Biochem, Canc Genet Lab, New Delhi, India
[3] SKIMS, Dept Radiat oncol, Srinagar, Jammu & Kashmir, India
关键词
Nonsmall cell lung cancer; adeno-carcinoma; squamous cell carcinoma; allele specific oligonucleotide; P53; (exon5; codon168) cytosine deletion;
D O I
10.4103/2278-330X.179701
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Lung cancer is considered to be the most common cancer in the world. In humans, about 50% or more cancers have a mutated tumor suppressor p53 gene thereby resulting in accumulation of p53 protein and losing its function to activate the target genes that regulate the cell cycle and apoptosis. Extensive research conducted in murine cancer models with activated p53, loss of p53, or p53 missense mutations have facilitated researchers to understand the role of this key protein. Our study was aimed to evaluate the frequency of cytosine deletion in nonsmall cell lung cancer (NSCLC) patients. Methods: One hundred NSCLC patients were genotyped for P53 (exon5, codon168) cytosine deletion leading to loss of its function and activate the target genes by allele-specific polymerase chain reaction. The P53 cytosine deletion was correlated with all the clinicopathological parameters of the patients. Results and Analysis: 59% cases were carrying P53 cytosine deletion. Similarly, the significantly higher incidence of cytosine deletion was reported in current smokers (75%) in comparison to exsmoker and nonsmoker. Significantly higher frequency of cytosine deletion was reported in adenocarcinoma (68.08%) than squamous cell carcinoma (52.83%). Also, a significant difference was reported between p53 cytosine deletion and metastasis (64.28%). Further, the majority of the cases assessed for response carrying P53 cytosine deletion were found to show faster disease progression. Conclusion: The data suggests that there is a significant association of the P53 exon 5 deletion of cytosine in codon 168 with metastasis and staging of the disease.
引用
收藏
页码:33 / +
页数:4
相关论文
共 50 条
  • [21] The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development
    Van Nostrand, Jeanine L.
    Brisac, Alice
    Mello, Stephano S.
    Jacobs, Suzanne B. R.
    Luong, Richard
    Attardi, Laura D.
    CANCER DISCOVERY, 2015, 5 (06) : 622 - 635
  • [22] High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer
    Chang, MY
    Chong, IW
    Chen, FM
    Wang, JY
    Cheng, TL
    Cheng, YJ
    Sheu, CC
    Hung, SY
    Yang, MC
    Lin, SR
    CANCER LETTERS, 2005, 222 (02) : 195 - 204
  • [23] High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan
    Wang, YC
    Chen, CY
    Chen, SK
    Cherng, SH
    Ho, WL
    Lee, H
    CANCER RESEARCH, 1998, 58 (02) : 328 - 333
  • [24] p53 mutations in non-small cell lung cancer in Poland
    Niklinski, J
    Rusin, M
    Chyczewski, L
    Sipowicz, M
    Shiao, YE
    Niklinska, WE
    Laudanski, J
    Furman, M
    Chorazy, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S30 - S30
  • [25] P53 IN NON-SMALL-CELL LUNG-CANCER - RESPONSE
    MITSUDOMI, T
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (10) : 802 - 803
  • [26] P53 as a prognostic indicator in non-small cell lung cancer
    Tsobanidou, Ch.
    Papageorgiou, A.
    Anestakis, D.
    Paraskevopoulos, P.
    Angel, J.
    Toliou, Th.
    LUNG CANCER, 2006, 52 : S39 - S39
  • [27] Lung cancer suppressor gene GPRC5A mediates p53 activity in non-small cell lung cancer cells in vitro
    Jin, Er
    Wang, Wenzhe
    Fang, Mengdie
    Wang, Limin
    Wu, Kan
    Zhang, Yemei
    Zhang, Shirong
    Ma, Shenglin
    MOLECULAR MEDICINE REPORTS, 2017, 16 (05) : 6382 - 6388
  • [28] P53 EXPRESSION IN NON-SMALL-CELL LUNG-CANCER - CLINICAL AND BIOLOGICAL CORRELATIONS
    FONTANINI, G
    BIGINI, D
    VIGNATI, S
    MACCHIARINI, P
    PEPE, S
    ANGELETTI, CA
    PINGITORE, R
    SQUARTINI, F
    ANTICANCER RESEARCH, 1993, 13 (03) : 737 - 742
  • [29] NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
    Wu, Nan
    Jia, Deshui
    Ibrahim, Ali H.
    Bachurski, Cindy J.
    Gronostajski, Richard M.
    MacPherson, David
    ONCOTARGET, 2016, 7 (36) : 57514 - 57524
  • [30] Clinical implications of the p53 gene
    Sidransky, D
    Hollstein, M
    ANNUAL REVIEW OF MEDICINE, 1996, 47 : 285 - 301